Emerade epinephrine auto-injectors are being recalled because the devices could fail.
Health Canada says the 0.3 and 0.5 milligram injectors could malfunction when people suffering a serious allergic reaction try to use them.
That means they might not get the epinephrine they need to stop potentially deadly anaphylaxis.
The recalled lots of Emerade, produced by Quebec-based Bausch Health, were distributed in Canada between April 2022 and May 2023.
Health Canada is urging people to take their Emerade auto-injectors to their pharmacies as soon as possible to get a replacement.
They should talk to the pharmacist to make sure they know how to use the replacement device before leaving the pharmacy, the health agency says.
Health Canada says if someone has a serious allergic reaction before they can get a new device, they should still use the old one and then seek emergency medical attention.
Anyone with questions about the recall can contact Bausch Health, Canada Inc. by calling 1-800-361-4261.
This report by The Canadian Press was first published May 8, 2023.
Canadian Press health coverage receives support through a partnership with the Canadian Medical Association. CP is solely responsible for this content.
JOIN THE CONVERSATION
Anyone can read Conversations, but to contribute, you should be a registered Torstar account holder. If you do not yet have a Torstar account, you can create one now (it is free)
does not endorse these opinions.
For all the latest Health News Click Here
For the latest news and updates, follow us on Google News.
